Structured evidence table for Ginger Dyspepsia Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Ginger Dyspepsia Meta-Analysis | The S1 guideline summarizes the current state of knowledge and allows a targeted approach based on the currently available medical evidence. | 2 | Storr M (2026) | S1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD), a Disorder of Gut-Brain Interaction (DGBI) [English Language Edition]. |
| Ginger Dyspepsia Meta-Analysis | Functional dyspepsia (FD) is common and classified as a disorder of gut-brain interaction (DGBI). | 2 | Storr M (2026) | S1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD), a Disorder of Gut-Brain Interaction (DGBI) [English Language Edition]. |
| Ginger Dyspepsia Meta-Analysis | Diagnosis is based on symptoms, which are classified according to the Rome IV criteria, in combination with diagnostic procedures that may include laboratory testing, Helicobacter pylori testing, upper gastrointestinal endoscopy, abdominal ultrasound, and other examinations, depending on the severity, duration, and presence of alarm symptoms. | 2 | Storr M (2026) | S1 Guideline of the German Society for Neurogastroenterology and Motility (DGNM) on Functional Dyspepsia (FD), a Disorder of Gut-Brain Interaction (DGBI) [English Language Edition]. |
| Ginger Dyspepsia Meta-Analysis | The evidence reported is predominantly preclinical ( in vitro and in vivo models), with more limited and heterogeneous clinical data. | 4 | Simeone P (2026) | Ginger Bioactives as Multi-Target Therapeutics: Mechanisms, Delivery Innovation, and Human Health Impact. |
| Ginger Dyspepsia Meta-Analysis | Background/Objectives : Ginger has a long history as both a culinary and medicinal plant and is widely recognized in traditional medicine for its ability to promote health and well-being. | 4 | Simeone P (2026) | Ginger Bioactives as Multi-Target Therapeutics: Mechanisms, Delivery Innovation, and Human Health Impact. |
| Ginger Dyspepsia Meta-Analysis | The principal bioactive compounds of ginger are present in fresh and dried forms and have been largely studied for their therapeutic potential. | 4 | Simeone P (2026) | Ginger Bioactives as Multi-Target Therapeutics: Mechanisms, Delivery Innovation, and Human Health Impact. |
Source documents